Delivery Order SPE2DB22D3301-SPE2DB24FY5GR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The Delivery Order contract, valued at $6,586.44, is for the supply of 4564731090 - YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of June 18, 2024 and is a firm fixed price arrangement. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $4,390.96 Firm Fixed Price Delivery Order is for the provision of 4564591085 - YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of June 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is a Delivery Order (SPE2DB24FZ2YH) with a Firm Fixed Price pricing type, valued at $17,563.84, to provide 4565456331 YONSA 125 MG TABLET 120S to the agency. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.74 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $2,195.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 4565826596 - YONSA 125 MG Tablet, 120 count, with an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which allow for the efficient procurement...
- This federal contract award SPE2DB20D3101|SPE2DB23FQTN5 was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,204.14 firm fixed price delivery order is for the supply of 4558941577 YONSA 125 MG TABLET 120S, with a completion date of November 22, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $13,172.88 for the supply of 4563982776 ! YONSA 125 MG TABLET 120S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, on March 15, 2024 with an ultimate completion date of April 5, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is a delivery order to provide the drug YONSA 125 MG TABLET 120S. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $6,586.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of 4564829489 - YONSA 125 MG TABLET 120S, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
- This federal contract award was issued by the Department of Defense (DoD) Medical Supply Chain to AmerisourceBergen Drug Corporation's Corporate Office Division. The $2,195.48 Firm Fixed Price Delivery Order is for the supply of 120 count bottles of the prescription drug YONSA 125 MG Tablet. The contract has a completion date of July 15, 2024 and does not have a set-aside designation. AmerisourceBergen, a leading pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY5GRDelivery Order
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY5GR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,954.80 firm fixed-price delivery order is for the supply of 4564375630 YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract award has no set-aside designation, indicating it was issued on a full and open competition basis. Amerisourcebergen Drug Corp, as the prime contractor, leverages its extensive pharmaceutical supply chain network to fulfill government contracts with federal agencies, including the Department of Defense and Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 4/23/24 |